Form D · Biotechnology
Rowan Scientific Corp
Allston, MA · CIK 0002037456
Offering snapshot reported Dec 20, 2024 · SEC filing
- Reported sold
- $2.17M Indefinite offering
- Investors reported
- 8 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jun 3, 2024 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 20, 2024 | Initial | $2,168,480 | No comparison | 8 | SEC filing |
Offering details
- Securities
- Debt, Option to acquire
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0 (estimated)
- Finders' fees
- $0 (estimated)
- Form D file number
- 021-532957
Source: Form D, filed Dec 20, 2024. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Corin Wagen | Director, Executive |
| Arien Wagen | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
121 Franklin Street #1
Allston, MA, 02134
Allston, MA, 02134